Article Details
Retrieved on: 2024-01-18 20:40:14
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Helix BioPharma Corp., a biopharmaceutical company in immuno-oncology, summarizing its annual shareholders' meeting where director elections, auditor appointment, and share consolidation were voted on, along with forward-looking statements about the company's future.
Article found on: www.marketscreener.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here